VMT-𝛼-GEN: Elegantly Designed Pb-212 Isotope Generator
Enables a nimble supply of therapeutic radioisotope with the power of alpha-particle therapy for cancer
Harnessing the Power of Alpha-Particles
We have developed a proprietary isotope generator, VMT-𝛼-GEN, to deliver our therapeutic isotope Pb-212 for supply to patients. With a half-life of 10.6 hours, Pb-212 is ideally suited to deliver powerful alpha-particle therapy to cancerous tumors, while representing a lower risk for off-target unintended effects and the potential for treatment on an outpatient basis.